Co-Diagnostics Market Cap

Co-Diagnostics has a market cap or net worth of 17.81 million as of February 21, 2025. Its market cap has decreased by -38.93% in one year.

Market Cap

17.81M

Enterprise Value

-10.11M

Revenue

5.46M

Ranking

n/a

PE Ratio

n/a

Stock Price

0.70

Market Cap Chart

Since July 12, 2017, Co-Diagnostics's market cap has decreased from 53.76M to 17.81M, a decrease of -66.88%. That is a compound annual growth rate of -13.50%.

Market Cap History

Date	Market Cap	% Change
Feb 21, 2025	17.81M	-6.91%
Dec 31, 2024	19.13M	-40.10%
Dec 29, 2023	31.93M	-50.62%
Dec 30, 2022	64.66M	-66.38%
Dec 31, 2021	192.31M	-0.13%
Dec 31, 2020	192.56M	1,542.95%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
AstraZeneca	179.71B
Shell	164.13B
HSBC Holdings	156.44B
Unilever	110.21B
Rio Tinto Group	85.95B
RELX PLC	73.75B
BP p.l.c.	70.76B
British American Tobacco p.l.c.	66.72B

Market Cap Rankings